Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CHASE CARDIOVASCULAR PATCH

K-Number: K001662 · 2000-08-02

ApplicantChase Medical, Inc.
Decision Date2000-08-02
Product CodeDXZ
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

CHASE CARDIOVASCULAR PATCH is the device name listed in this FDA 510(k) record. The listed applicant is Chase Medical, Inc.. It received FDA 510(k) clearance on 2000-08-02 under 510(k) number K001662. The device is classified under product code DXZ. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CHASE CARDIOVASCULAR PATCH?

CHASE CARDIOVASCULAR PATCH is a medical device that received FDA 510(k) clearance on 2000-08-02. The listed applicant is Chase Medical, Inc.. The 510(k) number is K001662.

When did CHASE CARDIOVASCULAR PATCH receive FDA 510(k) clearance?

CHASE CARDIOVASCULAR PATCH received FDA 510(k) clearance on 2000-08-02, under 510(k) number K001662.

Who is the listed applicant for CHASE CARDIOVASCULAR PATCH?

The FDA 510(k) record lists Chase Medical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CHASE CARDIOVASCULAR PATCH?

The FDA product code for CHASE CARDIOVASCULAR PATCH is DXZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Chase Medical, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K032531CHASE CARDIAC ANALYSIS SYSTEMK022093CHASE CARDIOVASCULAR PATCH KITK021129CHARE CARIOVASCULAR PATCHK020233CHASE CARDIOVASCULAR PATCH KITK020132CHASE CARDIOVASCULAR PATCH KITK012248CHASE CARDIOVASCULAR PATCH

View all 27 devices →

Related Devices (Code: DXZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K240775PeriBeam® Pericardial MembraneTamabioK200955Vascutek Gelseal Patch, Vascutek Gelsoft Patch, Vascutek Thin Wall Carotid PatchVascutek, Ltd.K162506PhotoFix Decellularized Bovine PericardiumCryolife, Inc.K162579VascuCelAdmedus Regen Pty, Ltd.K152127CorMatrix TykeCormatrix Cardiovascular, Inc.K122306SYNOVIS COLLAGEN MATRIX (TBD)Synovis Surgical Innovations

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑